Depression and Anxiety Trial, Recruiting NCT05762250 Sponsor: University Hospital Tuebingen Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05762250
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults with advanced cancer who are currently receiving treatment and experiencing ongoing physical or emotional symptoms related to their disease or treatment (assessed using a distress screening tool, with a score of 5 or higher)
  • People who have given their written agreement to take part in the study

Who may not be able to join:

  • People with a medical condition that, in the investigator's opinion, would prevent safe participation in the study
  • People with a mental health condition that, in the investigator's opinion, would prevent safe participation in the study
  • People who have planned radiation therapy directed at the head or skull area (to avoid the risk of scattered radiation)
  • People who have not provided a legally valid signed consent form
  • People who are currently taking part in another study involving acupuncture or acupressure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claudia Loeffler, Dr, Wuerzburg University Hospital

Phone: +49 93120144966

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Tuebingen
Registry
ClinicalTrials.gov
Start date
13 August 2023
Est. completion
1 June 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Change in disease-specific quality of life (FACT-MM)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov